Abstract
Summary
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global Phenylketonuria (PKU) market is projected to reach US$ 2653.6 million by 2030 from an estimated US$ 1481.6 million in 2024, at a CAGR of 10.2% during 2024 and 2030.
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phenylketonuria (PKU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Phenylketonuria (PKU).
The Phenylketonuria (PKU) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phenylketonuria (PKU) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenylketonuria (PKU) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Segment by Type
Medications
Supplements
Others
Segment by Application
Household
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Phenylketonuria (PKU) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phenylketonuria (PKU) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
This report mainly focuses on the treatment for PKU.
The global Phenylketonuria (PKU) market is projected to reach US$ 2653.6 million by 2030 from an estimated US$ 1481.6 million in 2024, at a CAGR of 10.2% during 2024 and 2030.
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phenylketonuria (PKU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Phenylketonuria (PKU).
The Phenylketonuria (PKU) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phenylketonuria (PKU) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phenylketonuria (PKU) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Segment by Type
Medications
Supplements
Others
Segment by Application
Household
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Phenylketonuria (PKU) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Phenylketonuria (PKU) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Phenylketonuria (PKU) Product Introduction
1.2 Market by Type
1.2.1 Global Phenylketonuria (PKU) Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Medications
1.2.3 Supplements
1.2.4 Others
1.3 Market by Application
1.3.1 Global Phenylketonuria (PKU) Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Household
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Phenylketonuria (PKU) Market Size Estimates and Forecasts
2.1.1 Global Phenylketonuria (PKU) Revenue 2019-2030
2.1.2 Global Phenylketonuria (PKU) Sales 2019-2030
2.2 Phenylketonuria (PKU) Market Size by Region: 2023 Versus 2030
2.3 Phenylketonuria (PKU) Sales by Region (2019-2030)
2.3.1 Global Phenylketonuria (PKU) Sales by Region: 2019-2024
2.3.2 Global Phenylketonuria (PKU) Sales Forecast by Region (2025-2030)
2.3.3 Global Phenylketonuria (PKU) Sales Market Share by Region (2019-2030)
2.4 Phenylketonuria (PKU) Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Phenylketonuria (PKU) Revenue by Region: 2019-2024
2.4.2 Global Phenylketonuria (PKU) Revenue Forecast by Region (2025-2030)
2.4.3 Global Phenylketonuria (PKU) Revenue Market Share by Region (2019-2030)
3 Global Phenylketonuria (PKU) by Manufacturers
3.1 Global Top Phenylketonuria (PKU) Manufacturers by Sales
3.1.1 Global Phenylketonuria (PKU) Sales by Manufacturer (2019-2024)
3.1.2 Global Phenylketonuria (PKU) Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Phenylketonuria (PKU) Manufacturers by Revenue
3.2.1 Global Phenylketonuria (PKU) Revenue by Manufacturer (2019-2024)
3.2.2 Global Phenylketonuria (PKU) Revenue Share by Manufacturer (2019-2024)
3.3 Global Phenylketonuria (PKU) Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Phenylketonuria (PKU) Manufacturers Covered: Ranking by Revenue
3.4.2 Global Phenylketonuria (PKU) Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Phenylketonuria (PKU) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Phenylketonuria (PKU) Manufacturing Base Distribution, Product Type
3.5.1 Phenylketonuria (PKU) Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Phenylketonuria (PKU) Product Type
3.5.3 Date of International Manufacturers Enter into Phenylketonuria (PKU) Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Biomarin
4.1.1 Biomarin Company Information
4.1.2 Biomarin Description, Business Overview
4.1.3 Biomarin Phenylketonuria (PKU) Products Offered
4.1.4 Biomarin Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Biomarin Phenylketonuria (PKU) Sales by Product in 2023
4.1.6 Biomarin Phenylketonuria (PKU) Sales by Application in 2023
4.1.7 Biomarin Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.1.8 Biomarin Recent Developments
4.2 Mead Johnson
4.2.1 Mead Johnson Company Information
4.2.2 Mead Johnson Description, Business Overview
4.2.3 Mead Johnson Phenylketonuria (PKU) Products Offered
4.2.4 Mead Johnson Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Mead Johnson Phenylketonuria (PKU) Sales by Product in 2023
4.2.6 Mead Johnson Phenylketonuria (PKU) Sales by Application in 2023
4.2.7 Mead Johnson Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.2.8 Mead Johnson Recent Developments
4.3 Abbott
4.3.1 Abbott Company Information
4.3.2 Abbott Description, Business Overview
4.3.3 Abbott Phenylketonuria (PKU) Products Offered
4.3.4 Abbott Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Abbott Phenylketonuria (PKU) Sales by Product in 2023
4.3.6 Abbott Phenylketonuria (PKU) Sales by Application in 2023
4.3.7 Abbott Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.3.8 Abbott Recent Developments
4.4 Nutricia
4.4.1 Nutricia Company Information
4.4.2 Nutricia Description, Business Overview
4.4.3 Nutricia Phenylketonuria (PKU) Products Offered
4.4.4 Nutricia Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Nutricia Phenylketonuria (PKU) Sales by Product in 2023
4.4.6 Nutricia Phenylketonuria (PKU) Sales by Application in 2023
4.4.7 Nutricia Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.4.8 Nutricia Recent Developments
4.5 Dr. Schär
4.5.1 Dr. Schär Company Information
4.5.2 Dr. Schär Description, Business Overview
4.5.3 Dr. Schär Phenylketonuria (PKU) Products Offered
4.5.4 Dr. Schär Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Dr. Schär Phenylketonuria (PKU) Sales by Product in 2023
4.5.6 Dr. Schär Phenylketonuria (PKU) Sales by Application in 2023
4.5.7 Dr. Schär Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.5.8 Dr. Schär Recent Developments
4.6 Vitaflo
4.6.1 Vitaflo Company Information
4.6.2 Vitaflo Description, Business Overview
4.6.3 Vitaflo Phenylketonuria (PKU) Products Offered
4.6.4 Vitaflo Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Vitaflo Phenylketonuria (PKU) Sales by Product in 2023
4.6.6 Vitaflo Phenylketonuria (PKU) Sales by Application in 2023
4.6.7 Vitaflo Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.6.8 Vitaflo Recent Development
4.7 Cambrooke
4.7.1 Cambrooke Company Information
4.7.2 Cambrooke Description, Business Overview
4.7.3 Cambrooke Phenylketonuria (PKU) Products Offered
4.7.4 Cambrooke Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Cambrooke Phenylketonuria (PKU) Sales by Product in 2023
4.7.6 Cambrooke Phenylketonuria (PKU) Sales by Application in 2023
4.7.7 Cambrooke Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.7.8 Cambrooke Recent Development
4.8 PKU Perspectives
4.8.1 PKU Perspectives Company Information
4.8.2 PKU Perspectives Description, Business Overview
4.8.3 PKU Perspectives Phenylketonuria (PKU) Products Offered
4.8.4 PKU Perspectives Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.8.5 PKU Perspectives Phenylketonuria (PKU) Sales by Product in 2023
4.8.6 PKU Perspectives Phenylketonuria (PKU) Sales by Application in 2023
4.8.7 PKU Perspectives Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.8.8 PKU Perspectives Recent Development
4.9 Firstplay Dietary
4.9.1 Firstplay Dietary Company Information
4.9.2 Firstplay Dietary Description, Business Overview
4.9.3 Firstplay Dietary Phenylketonuria (PKU) Products Offered
4.9.4 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Firstplay Dietary Phenylketonuria (PKU) Sales by Product in 2023
4.9.6 Firstplay Dietary Phenylketonuria (PKU) Sales by Application in 2023
4.9.7 Firstplay Dietary Phenylketonuria (PKU) Sales by Geographic Area in 2023
4.9.8 Firstplay Dietary Recent Development
5 Breakdown Data by Type
5.1 Global Phenylketonuria (PKU) Sales by Type (2019-2030)
5.1.1 Global Phenylketonuria (PKU) Sales by Type (2019-2024)
5.1.2 Global Phenylketonuria (PKU) Sales Forecast by Type (2025-2030)
5.1.3 Global Phenylketonuria (PKU) Sales Market Share by Type (2019-2030)
5.2 Global Phenylketonuria (PKU) Revenue Forecast by Type (2019-2030)
5.2.1 Global Phenylketonuria (PKU) Revenue by Type (2019-2024)
5.2.2 Global Phenylketonuria (PKU) Revenue Forecast by Type (2025-2030)
5.2.3 Global Phenylketonuria (PKU) Revenue Market Share by Type (2019-2030)
5.3 Phenylketonuria (PKU) Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Phenylketonuria (PKU) Sales by Application (2019-2030)
6.1.1 Global Phenylketonuria (PKU) Sales by Application (2019-2024)
6.1.2 Global Phenylketonuria (PKU) Sales Forecast by Application (2025-2030)
6.1.3 Global Phenylketonuria (PKU) Sales Market Share by Application (2019-2030)
6.2 Global Phenylketonuria (PKU) Revenue Forecast by Application (2019-2030)
6.2.1 Global Phenylketonuria (PKU) Revenue by Application (2019-2024)
6.2.2 Global Phenylketonuria (PKU) Revenue Forecast by Application (2025-2030)
6.2.3 Global Phenylketonuria (PKU) Revenue Market Share by Application (2019-2030)
6.3 Phenylketonuria (PKU) Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Phenylketonuria (PKU) Market Size YoY Growth 2019-2030
7.2 North America Phenylketonuria (PKU) Market Facts & Figures by Country
7.2.1 North America Phenylketonuria (PKU) Sales by Country (2019-2030)
7.2.2 North America Phenylketonuria (PKU) Revenue by Country (2019-2030)
7.3 North America Phenylketonuria (PKU) Sales by Type (2019-2024)
7.4 North America Phenylketonuria (PKU) Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Phenylketonuria (PKU) Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Phenylketonuria (PKU) Market Facts & Figures by Region
8.2.1 Asia-Pacific Phenylketonuria (PKU) Sales by Region (2019-2030)
8.2.2 Asia-Pacific Phenylketonuria (PKU) Revenue by Region (2019-2030)
8.3 Asia-Pacific Phenylketonuria (PKU) Sales by Type (2019-2024)
8.4 Asia-Pacific Phenylketonuria (PKU) Sales by Application (2019-2024)
9 Europe
9.1 Europe Phenylketonuria (PKU) Market Size YoY Growth 2019-2030
9.2 Europe Phenylketonuria (PKU) Market Facts & Figures by Country
9.2.1 Europe Phenylketonuria (PKU) Sales by Country (2019-2030)
9.2.2 Europe Phenylketonuria (PKU) Revenue by Country (2019-2030)
9.3 Europe Phenylketonuria (PKU) Sales by Type (2019-2024)
9.4 Europe Phenylketonuria (PKU) Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Phenylketonuria (PKU) Market Size YoY Growth 2019-2030
10.2 Latin America Phenylketonuria (PKU) Market Facts & Figures by Country
10.2.1 Latin America Phenylketonuria (PKU) Sales by Country (2019-2030)
10.2.2 Latin America Phenylketonuria (PKU) Revenue by Country (2019-2030)
10.3 Latin America Phenylketonuria (PKU) Sales by Type (2019-2024)
10.4 Latin America Phenylketonuria (PKU) Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Phenylketonuria (PKU) Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Phenylketonuria (PKU) Market Facts & Figures by Country
11.2.1 Middle East and Africa Phenylketonuria (PKU) Sales by Country (2019-2030)
11.2.2 Middle East and Africa Phenylketonuria (PKU) Revenue by Country (2019-2030)
11.3 Middle East and Africa Phenylketonuria (PKU) Sales by Type (2019-2024)
11.4 Middle East and Africa Phenylketonuria (PKU) Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Phenylketonuria (PKU) Supply Chain Analysis
12.2 Phenylketonuria (PKU) Key Raw Materials and Upstream Suppliers
12.3 Phenylketonuria (PKU) Clients Analysis
12.4 Phenylketonuria (PKU) Sales Channel and Sales Model Analysis
12.4.1 Phenylketonuria (PKU) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Phenylketonuria (PKU) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Phenylketonuria (PKU) Distributors
13 Market Dynamics
13.1 Phenylketonuria (PKU) Industry Trends
13.2 Phenylketonuria (PKU) Market Drivers
13.3 Phenylketonuria (PKU) Market Challenges
13.4 Phenylketonuria (PKU) Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer